Skip to main content
Erschienen in: Drugs & Aging 1/2009

01.12.2009 | Review Article

Development of CRIteria to Assess Appropriate Medication Use among Elderly Complex Patients (CRIME) Project

Rationale and Methodology

verfasst von: Domenico Fusco, Fabrizia Lattanzio, Matteo Tosato, Andrea Corsonello, Antonio Cherubini, Stefano Volpato, Cinzia Maraldi, Carmelinda Ruggiero, Dr Graziano Onder

Erschienen in: Drugs & Aging | Sonderheft 1/2009

Einloggen, um Zugang zu erhalten

Abstract

Pharmacological treatment of complex older adults with comorbidities, multiple impairments in function, cognition, social status and geriatric syndromes represents a challenge for prescribing physicians and often results in a high rate of iatrogenic illnesses. Clinical guidelines are commonly used to indicate appropriate prescription, but they are often based on the results of clinical trials that are conducted on young subjects with a low level of complexity. Therefore, the recommendations of clinical guidelines may be difficult to apply to older complex adults. In this paper we present the rationale and methodology of the Development of CRIteria to assess appropriate Medication use among Elderly complex patients (CRIME) project, a study aimed at producing recommendations to evaluate the appropriateness of pharmacological prescription in older complex patients, translating the recommendations of clinical guidelines to this type of patient. A literature search will be performed to integrate and revise the recommendations of disease-specific guidelines on the pharmacological treatment of patients with common chronic conditions. New recommendations will be provided and approved in a consensus meeting of international experts. Both data from randomized controlled trials and observational studies will be used to meet this aim. Recommendations provided by the CRIME project are not meant to replace existing clinical guidelines, but they may be used to help physicians in the prescribing process. Once completed these recommendations should be validated in interventional studies.
Literatur
1.
Zurück zum Zitat Inouye SK, Studenski S, Tinetti M, et al. Geriatric syndromes: clinical, research, and policy implications of a core geriatric concept. J Am Geriatr Soc 2007; 55: 780–91PubMedCrossRef Inouye SK, Studenski S, Tinetti M, et al. Geriatric syndromes: clinical, research, and policy implications of a core geriatric concept. J Am Geriatr Soc 2007; 55: 780–91PubMedCrossRef
2.
Zurück zum Zitat Lee PG, Cigolle C, Blaum C. The co-occurrence of chronic diseases and geriatric syndromes: the Health and Retirement Study. J Am Geriatr Soc 2009; 57: 511–16PubMedCrossRef Lee PG, Cigolle C, Blaum C. The co-occurrence of chronic diseases and geriatric syndromes: the Health and Retirement Study. J Am Geriatr Soc 2009; 57: 511–16PubMedCrossRef
3.
Zurück zum Zitat Cesari M, Onder G, Russo A, et al. Comorbidity and physical function: results from the aging and longevity study in the Sirente geographic area (ilSIRENTE study). Gerontology 2006; 52(1): 24–32PubMedCrossRef Cesari M, Onder G, Russo A, et al. Comorbidity and physical function: results from the aging and longevity study in the Sirente geographic area (ilSIRENTE study). Gerontology 2006; 52(1): 24–32PubMedCrossRef
4.
Zurück zum Zitat Wolff JL, Starfield B, Anderson G. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med 2002; 162: 2269–76PubMedCrossRef Wolff JL, Starfield B, Anderson G. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med 2002; 162: 2269–76PubMedCrossRef
5.
Zurück zum Zitat Spinewine A, Schmader KE, Barber N, et al. Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet 2007; 370: 173–84PubMedCrossRef Spinewine A, Schmader KE, Barber N, et al. Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet 2007; 370: 173–84PubMedCrossRef
6.
Zurück zum Zitat Onder G, Pedone C, Landi F, et al. Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). J Am Geriatr Soc 2002; 50: 1962–8PubMedCrossRef Onder G, Pedone C, Landi F, et al. Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). J Am Geriatr Soc 2002; 50: 1962–8PubMedCrossRef
7.
Zurück zum Zitat Olivier P, Bertrand L, Tubery M, et al. Hospitalizations because of adverse drug reactions in elderly patients admitted through the emergency department: a prospective survey. Drugs Aging 2009; 26: 475–82PubMedCrossRef Olivier P, Bertrand L, Tubery M, et al. Hospitalizations because of adverse drug reactions in elderly patients admitted through the emergency department: a prospective survey. Drugs Aging 2009; 26: 475–82PubMedCrossRef
8.
Zurück zum Zitat Zhang M, Holman CD, Price SD, et al. Comorbidity and repeat admission to hospital for adverse drug reactions in older adults: retrospective cohort study. BMJ 2009; 338: a2752. doi: 10.1136/bmj.a2752PubMedCrossRef Zhang M, Holman CD, Price SD, et al. Comorbidity and repeat admission to hospital for adverse drug reactions in older adults: retrospective cohort study. BMJ 2009; 338: a2752. doi: 10.1136/bmj.a2752PubMedCrossRef
9.
Zurück zum Zitat Gurwitz JH, Rochon P. Improving the quality of medication use in elderly patients: a not-so-simple prescription. Arch Intern Med 2002; 162: 1670–2PubMedCrossRef Gurwitz JH, Rochon P. Improving the quality of medication use in elderly patients: a not-so-simple prescription. Arch Intern Med 2002; 162: 1670–2PubMedCrossRef
10.
Zurück zum Zitat Catananti C, Liperoti R, Settanni S, et al. Heart failure and adverse drug reactions among hospitalized older adults. Clin Pharmacol Ther 2009; 86: 307–10PubMedCrossRef Catananti C, Liperoti R, Settanni S, et al. Heart failure and adverse drug reactions among hospitalized older adults. Clin Pharmacol Ther 2009; 86: 307–10PubMedCrossRef
11.
Zurück zum Zitat Helldén A, Bergman U, von Euler M, et al. Adverse drug reactions and impaired renal function in elderly patients admitted to the emergency department: a retrospective study. Drugs Aging 2009; 26: 595–606PubMedCrossRef Helldén A, Bergman U, von Euler M, et al. Adverse drug reactions and impaired renal function in elderly patients admitted to the emergency department: a retrospective study. Drugs Aging 2009; 26: 595–606PubMedCrossRef
12.
Zurück zum Zitat Corsonello A, Pedone C, Corica F, et al., Gruppo Italiano di Farmacovigilanza nell’Anziano (GIFA) Investigators. Concealed renal insufficiency and adverse drug reactions in elderly hospitalized patients. Arch Intern Med 2005; 165: 790–5PubMedCrossRef Corsonello A, Pedone C, Corica F, et al., Gruppo Italiano di Farmacovigilanza nell’Anziano (GIFA) Investigators. Concealed renal insufficiency and adverse drug reactions in elderly hospitalized patients. Arch Intern Med 2005; 165: 790–5PubMedCrossRef
13.
Zurück zum Zitat Rochon PA, Gurwitz JH. Optimising drug treatment for elderly people: the prescribing cascade. BMJ 1997; 315: 1096–9PubMedCrossRef Rochon PA, Gurwitz JH. Optimising drug treatment for elderly people: the prescribing cascade. BMJ 1997; 315: 1096–9PubMedCrossRef
14.
Zurück zum Zitat Tulner LR, Frankfort SV, Gijsen GJ, et al. Drug-drug interactions in a geriatric outpatient cohort: prevalence and relevance. Drugs Aging 2008; 25: 343–55PubMedCrossRef Tulner LR, Frankfort SV, Gijsen GJ, et al. Drug-drug interactions in a geriatric outpatient cohort: prevalence and relevance. Drugs Aging 2008; 25: 343–55PubMedCrossRef
15.
Zurück zum Zitat Becker ML, Visser LE, van Gelder T, et al. Increasing exposure to drug-drug interactions between 1992 and 2005 in people aged > or =55 years. Drugs Aging 2008; 25: 145–52PubMedCrossRef Becker ML, Visser LE, van Gelder T, et al. Increasing exposure to drug-drug interactions between 1992 and 2005 in people aged > or =55 years. Drugs Aging 2008; 25: 145–52PubMedCrossRef
16.
Zurück zum Zitat Fialová D, Onder G. Medication errors in elderly people: contributing factors and future perspectives. Br J Clin Pharmacol 2009; 67: 641–5PubMedCrossRef Fialová D, Onder G. Medication errors in elderly people: contributing factors and future perspectives. Br J Clin Pharmacol 2009; 67: 641–5PubMedCrossRef
17.
Zurück zum Zitat Corsonello A, Pedone C, Lattanzio F, et al., PharmacosurVeillance in the Elderly Care Study Group. Potentially inappropriate medications and functional decline in elderly hospitalized patients. J Am Geriatr Soc 2009; 57: 1007–14PubMedCrossRef Corsonello A, Pedone C, Lattanzio F, et al., PharmacosurVeillance in the Elderly Care Study Group. Potentially inappropriate medications and functional decline in elderly hospitalized patients. J Am Geriatr Soc 2009; 57: 1007–14PubMedCrossRef
18.
Zurück zum Zitat Stuijt CC, Franssen EJ, Egberts AC, et al. Appropriateness of prescribing among elderly patients in a Dutch residential home: observational study of outcomes after a pharmacistled medication review. Drugs Aging 2008; 25: 947–54PubMedCrossRef Stuijt CC, Franssen EJ, Egberts AC, et al. Appropriateness of prescribing among elderly patients in a Dutch residential home: observational study of outcomes after a pharmacistled medication review. Drugs Aging 2008; 25: 947–54PubMedCrossRef
19.
Zurück zum Zitat Hosia-Randell HM, Muurinen SM, Pitkälä KH. Exposure to potentially inappropriate drugs and drug-drug interactions in elderly nursing home residents in Helsinki, Finland: a cross-sectional study. Drugs Aging 2008; 25: 683–92PubMedCrossRef Hosia-Randell HM, Muurinen SM, Pitkälä KH. Exposure to potentially inappropriate drugs and drug-drug interactions in elderly nursing home residents in Helsinki, Finland: a cross-sectional study. Drugs Aging 2008; 25: 683–92PubMedCrossRef
20.
Zurück zum Zitat Fialová D, Topinková E, Gambassi G, et al., AdHOC Project Research Group. Potentially inappropriate medication use among elderly home care patients in Europe. JAMA 2005; 293: 1348–58PubMedCrossRef Fialová D, Topinková E, Gambassi G, et al., AdHOC Project Research Group. Potentially inappropriate medication use among elderly home care patients in Europe. JAMA 2005; 293: 1348–58PubMedCrossRef
21.
Zurück zum Zitat Onder G, Landi F, Liperoti R, et al. Impact of inappropriate drug use among hospitalized older adults. Eur J Clin Pharmacol 2005; 61: 453–9PubMedCrossRef Onder G, Landi F, Liperoti R, et al. Impact of inappropriate drug use among hospitalized older adults. Eur J Clin Pharmacol 2005; 61: 453–9PubMedCrossRef
22.
Zurück zum Zitat Agashivala N, Wu WK. Effects of potentially inappropriate psychoactive medications on falls in US nursing home residents: analysis of the 2004 National Nursing Home Survey database. Drugs Aging 2009; 26: 853–60PubMedCrossRef Agashivala N, Wu WK. Effects of potentially inappropriate psychoactive medications on falls in US nursing home residents: analysis of the 2004 National Nursing Home Survey database. Drugs Aging 2009; 26: 853–60PubMedCrossRef
23.
Zurück zum Zitat Onder G, Landi F, Cesari M, et al., Investigators of the GIFA Study. Inappropriate medication use among hospitalized older adults in Italy: results from the Italian Group of Pharmacoepidemiology in the Elderly. Eur J Clin Pharmacol 2003; 59: 157–62PubMed Onder G, Landi F, Cesari M, et al., Investigators of the GIFA Study. Inappropriate medication use among hospitalized older adults in Italy: results from the Italian Group of Pharmacoepidemiology in the Elderly. Eur J Clin Pharmacol 2003; 59: 157–62PubMed
24.
Zurück zum Zitat Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003; 163: 2716–24PubMedCrossRef Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003; 163: 2716–24PubMedCrossRef
25.
Zurück zum Zitat Hanlon JT, Schmader KE, Samsa GP, et al. A method for assessing drug therapy appropriateness. J Clin Epidemiol 1992; 45: 1045–51PubMedCrossRef Hanlon JT, Schmader KE, Samsa GP, et al. A method for assessing drug therapy appropriateness. J Clin Epidemiol 1992; 45: 1045–51PubMedCrossRef
26.
Zurück zum Zitat Wenger NS, Shekelle PG. Assessing care of vulnerable elders: ACOVE project overview. Ann Intern Med 2001; 135: 642–6PubMed Wenger NS, Shekelle PG. Assessing care of vulnerable elders: ACOVE project overview. Ann Intern Med 2001; 135: 642–6PubMed
27.
Zurück zum Zitat Gallagher P, Ryan C, Byrne S, et al. STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther 2008; 46: 72–83PubMed Gallagher P, Ryan C, Byrne S, et al. STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther 2008; 46: 72–83PubMed
28.
Zurück zum Zitat Boyd CM, Darer J, Boult C, et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA 2005; 294: 716–24PubMedCrossRef Boyd CM, Darer J, Boult C, et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA 2005; 294: 716–24PubMedCrossRef
29.
Zurück zum Zitat Tinetti ME, Bogardus Jr ST, Agostini JV. Potential pitfalls of disease-specific guidelines for patients with multiple conditions. N Engl J Med 2004; 351: 2870–4PubMedCrossRef Tinetti ME, Bogardus Jr ST, Agostini JV. Potential pitfalls of disease-specific guidelines for patients with multiple conditions. N Engl J Med 2004; 351: 2870–4PubMedCrossRef
30.
Zurück zum Zitat Rhalimi M, Helou R, Jaecker P. Medication use and increased risk of falls in hospitalized elderly patients: a retrospective, case-control study. Drugs Aging 2009; 26: 847–52PubMedCrossRef Rhalimi M, Helou R, Jaecker P. Medication use and increased risk of falls in hospitalized elderly patients: a retrospective, case-control study. Drugs Aging 2009; 26: 847–52PubMedCrossRef
31.
Zurück zum Zitat Nishtala PS, Hilmer SN, McLachlan AJ, et al. Impact of residential medication management reviews on drug burden index in aged-care homes: a retrospective analysis. Drugs Aging 2009; 26: 677–86PubMedCrossRef Nishtala PS, Hilmer SN, McLachlan AJ, et al. Impact of residential medication management reviews on drug burden index in aged-care homes: a retrospective analysis. Drugs Aging 2009; 26: 677–86PubMedCrossRef
32.
Zurück zum Zitat Cayea D, Boyd C, Durso SC. Individualising therapy for older adults with diabetes mellitus. Drugs Aging 2007; 24: 851–63PubMedCrossRef Cayea D, Boyd C, Durso SC. Individualising therapy for older adults with diabetes mellitus. Drugs Aging 2007; 24: 851–63PubMedCrossRef
33.
Zurück zum Zitat Holmes HM, Hayley DC, Alexander GC, et al. Reconsidering medication appropriateness for patients late in life. Arch Intern Med 2006; 166: 605–9PubMedCrossRef Holmes HM, Hayley DC, Alexander GC, et al. Reconsidering medication appropriateness for patients late in life. Arch Intern Med 2006; 166: 605–9PubMedCrossRef
34.
Zurück zum Zitat Marengoni A, von Strauss E, Rizzuto D, et al. The impact of chronic multimorbidity and disability on functional decline and survival in elderly persons. A community-based, longitudinal study. J Intern Med 2009; 265: 288–95PubMedCrossRef Marengoni A, von Strauss E, Rizzuto D, et al. The impact of chronic multimorbidity and disability on functional decline and survival in elderly persons. A community-based, longitudinal study. J Intern Med 2009; 265: 288–95PubMedCrossRef
35.
Zurück zum Zitat Verbrugge LM, Lepkowski JM, Imanaka Y. Comorbidity and its impact on disability. Milbank Q 1989; 67: 450–84PubMedCrossRef Verbrugge LM, Lepkowski JM, Imanaka Y. Comorbidity and its impact on disability. Milbank Q 1989; 67: 450–84PubMedCrossRef
36.
Zurück zum Zitat Yancik R, Ershler W, Satariano W, et al. Report of the national institute on aging task force on comorbidity. J Gerontol A Biol Sci Med Sci 2007; 62: 275–80PubMedCrossRef Yancik R, Ershler W, Satariano W, et al. Report of the national institute on aging task force on comorbidity. J Gerontol A Biol Sci Med Sci 2007; 62: 275–80PubMedCrossRef
37.
Zurück zum Zitat Lee SJ, Lindquist K, Segal MR, et al. Development and validation of a prognostic index for 4-year mortality in older adults. JAMA 2006; 295: 801–8PubMedCrossRef Lee SJ, Lindquist K, Segal MR, et al. Development and validation of a prognostic index for 4-year mortality in older adults. JAMA 2006; 295: 801–8PubMedCrossRef
38.
Zurück zum Zitat Huang ES. Appropriate application of evidence to the care of elderly patients with diabetes. Curr Diabetes Rev 2007; 3: 260–3PubMedCrossRef Huang ES. Appropriate application of evidence to the care of elderly patients with diabetes. Curr Diabetes Rev 2007; 3: 260–3PubMedCrossRef
39.
Zurück zum Zitat Gage BF, Birman-Deych E, Kerzner R, et al. Incidence of intracranial hemorrhage in patients with atrial fibrillation who are prone to fall. Am J Med 2005; 118: 612–17PubMedCrossRef Gage BF, Birman-Deych E, Kerzner R, et al. Incidence of intracranial hemorrhage in patients with atrial fibrillation who are prone to fall. Am J Med 2005; 118: 612–17PubMedCrossRef
40.
Zurück zum Zitat Fedorowski A, Stavenow L, Hedblad B, et al. Orthostatic hypotension predicts all-cause mortality and coronary events in middle-aged individuals (The Malmo Preventive Project). Eur Heart J 2009 Aug 20; [Epub ahead of print] Fedorowski A, Stavenow L, Hedblad B, et al. Orthostatic hypotension predicts all-cause mortality and coronary events in middle-aged individuals (The Malmo Preventive Project). Eur Heart J 2009 Aug 20; [Epub ahead of print]
41.
Zurück zum Zitat Arlt S, Lindner R, Rösler A, et al. Adherence to medication in patients with dementia: predictors and strategies for improvement. Drugs Aging 2008; 25: 1033–47PubMedCrossRef Arlt S, Lindner R, Rösler A, et al. Adherence to medication in patients with dementia: predictors and strategies for improvement. Drugs Aging 2008; 25: 1033–47PubMedCrossRef
42.
Zurück zum Zitat Brauner DJ, Muir JC, Sachs GA. Treating nondementia illnesses in patients with dementia. JAMA 2000; 283: 3230–5PubMedCrossRef Brauner DJ, Muir JC, Sachs GA. Treating nondementia illnesses in patients with dementia. JAMA 2000; 283: 3230–5PubMedCrossRef
43.
Zurück zum Zitat Nikolaus T, Kruse W, Bach M, et al. Elderly patients’ problems with medication: an in-hospital and follow-up study. Eur J Clin Pharmacol 1996; 49: 255–9PubMedCrossRef Nikolaus T, Kruse W, Bach M, et al. Elderly patients’ problems with medication: an in-hospital and follow-up study. Eur J Clin Pharmacol 1996; 49: 255–9PubMedCrossRef
44.
Zurück zum Zitat Beckman AG, Parker MG, Thorslund M. Can elderly people take their medicine? Patient Educ Couns 2005; 59: 186–91PubMedCrossRef Beckman AG, Parker MG, Thorslund M. Can elderly people take their medicine? Patient Educ Couns 2005; 59: 186–91PubMedCrossRef
45.
Zurück zum Zitat American Diabetes Association. Standards of medical care in diabetes — 2009. Diabetes Care 2009; 32Suppl. 1: S13–61CrossRef American Diabetes Association. Standards of medical care in diabetes — 2009. Diabetes Care 2009; 32Suppl. 1: S13–61CrossRef
46.
Zurück zum Zitat Brown AF, Mangione CM, Saliba D, et al. Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc 2003; 51 (5 Suppl.): S265–80PubMedCrossRef Brown AF, Mangione CM, Saliba D, et al. Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc 2003; 51 (5 Suppl.): S265–80PubMedCrossRef
47.
Zurück zum Zitat IDF Clinical Guidelines Task Force. Global Guideline for Type 2 Diabetes: recommendations for standard, comprehensive, and minimal care. Diabet Med 2006; 23: 579–93CrossRef IDF Clinical Guidelines Task Force. Global Guideline for Type 2 Diabetes: recommendations for standard, comprehensive, and minimal care. Diabet Med 2006; 23: 579–93CrossRef
48.
Zurück zum Zitat The UK Prospective Diabetes Study (UKPDS) Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837–53CrossRef The UK Prospective Diabetes Study (UKPDS) Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837–53CrossRef
49.
Zurück zum Zitat Gerstein HC, Miller ME, Byington RP, et al., Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358: 2545–59PubMedCrossRef Gerstein HC, Miller ME, Byington RP, et al., Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358: 2545–59PubMedCrossRef
50.
Zurück zum Zitat Patel A, MacMahon S, Chalmers J, et al., ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358: 2560–72PubMedCrossRef Patel A, MacMahon S, Chalmers J, et al., ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358: 2560–72PubMedCrossRef
51.
Zurück zum Zitat Duckworth W, Abraira C, Moritz T, et al. Intensive glucose control and complications in American veterans with type 2 diabetes. N Engl J Med 2009; 360: 129–39PubMedCrossRef Duckworth W, Abraira C, Moritz T, et al. Intensive glucose control and complications in American veterans with type 2 diabetes. N Engl J Med 2009; 360: 129–39PubMedCrossRef
52.
Zurück zum Zitat Ray KK, Seshasai SR, Wijesuriya S, et al. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet 2009; 373: 1765–72PubMedCrossRef Ray KK, Seshasai SR, Wijesuriya S, et al. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet 2009; 373: 1765–72PubMedCrossRef
53.
Zurück zum Zitat Bremer JP, Jauch-Chara K, Hallschmid M, et al. Hypoglycemia unawareness in older compared with middle-aged patients with type 2 diabetes. Diabetes Care 2009; 32(8): 1513–7PubMedCrossRef Bremer JP, Jauch-Chara K, Hallschmid M, et al. Hypoglycemia unawareness in older compared with middle-aged patients with type 2 diabetes. Diabetes Care 2009; 32(8): 1513–7PubMedCrossRef
54.
Zurück zum Zitat Chelliah A, Burge MR. Hypoglycaemia in Elderly Patients with Diabetes Mellitus. Causes and Strategies for Prevention. Drugs Aging 2004; 21(8): 511–30PubMedCrossRef Chelliah A, Burge MR. Hypoglycaemia in Elderly Patients with Diabetes Mellitus. Causes and Strategies for Prevention. Drugs Aging 2004; 21(8): 511–30PubMedCrossRef
55.
Zurück zum Zitat Vijan S, Hofer TP, Hayward RA. Estimated benefits of glycemic control in microvascular complications in type 2 diabetes. Ann Intern Med 1997; 127: 788–95PubMed Vijan S, Hofer TP, Hayward RA. Estimated benefits of glycemic control in microvascular complications in type 2 diabetes. Ann Intern Med 1997; 127: 788–95PubMed
56.
Zurück zum Zitat Huang ES, Zhang Q, Gandra N, et al. The effect of comorbid illness and functional status on the expected benefits of intensive glucose control in older patients with type 2 diabetes: a decision analysis. Ann Intern Med 2008; 149: 11–9PubMed Huang ES, Zhang Q, Gandra N, et al. The effect of comorbid illness and functional status on the expected benefits of intensive glucose control in older patients with type 2 diabetes: a decision analysis. Ann Intern Med 2008; 149: 11–9PubMed
57.
Zurück zum Zitat Durso SC. Using clinical guidelines designed for older adults with diabetes mellitus and complex health status. JAMA 2006; 295: 1935–40PubMedCrossRef Durso SC. Using clinical guidelines designed for older adults with diabetes mellitus and complex health status. JAMA 2006; 295: 1935–40PubMedCrossRef
58.
Zurück zum Zitat Schwartz AV, Vittinghoff E, Sellmeyer DE. Diabetes-related complications, glycemic control, and falls in older adults. Diabetes Care 2008; 31: 391–6PubMedCrossRef Schwartz AV, Vittinghoff E, Sellmeyer DE. Diabetes-related complications, glycemic control, and falls in older adults. Diabetes Care 2008; 31: 391–6PubMedCrossRef
59.
Zurück zum Zitat Monami M, Cresci B, Colombini A. Bone fractures and hypoglycemic treatment in type 2 diabetic patients: a case-control study. Diabetes Care 2008; 31: 199–203PubMedCrossRef Monami M, Cresci B, Colombini A. Bone fractures and hypoglycemic treatment in type 2 diabetic patients: a case-control study. Diabetes Care 2008; 31: 199–203PubMedCrossRef
60.
Zurück zum Zitat Volpato S, Leveille SG, Blaum C. Risk Factors for Falls in Older Disabled Women With Diabetes: The Women’s Health and Aging Study. J Gerontol A Biol Sci Med Sci 2005 Dec; 60(12): 1539–45PubMedCrossRef Volpato S, Leveille SG, Blaum C. Risk Factors for Falls in Older Disabled Women With Diabetes: The Women’s Health and Aging Study. J Gerontol A Biol Sci Med Sci 2005 Dec; 60(12): 1539–45PubMedCrossRef
61.
Zurück zum Zitat Nelson JM, Dufraux K, Cook PF. The relationship between glycemic control and falls in older adults. J Am Geriatr Soc 2007; 55: 2041–4PubMedCrossRef Nelson JM, Dufraux K, Cook PF. The relationship between glycemic control and falls in older adults. J Am Geriatr Soc 2007; 55: 2041–4PubMedCrossRef
62.
Zurück zum Zitat Heisler M, Cole I, Weir D, et al. Does physician communication influence older patients’ diabetes self-management and glycemic control? Results from the Health and Retirement Study (HRS). J Gerontol A Biol Sci Med Sci 2007; 62(12): 1435–42PubMedCrossRef Heisler M, Cole I, Weir D, et al. Does physician communication influence older patients’ diabetes self-management and glycemic control? Results from the Health and Retirement Study (HRS). J Gerontol A Biol Sci Med Sci 2007; 62(12): 1435–42PubMedCrossRef
63.
Zurück zum Zitat Schillinger D, Grumbach K, Piette J. Association of health literacy with diabetes outcomes. JAMA 2002; 288(4): 475–82PubMedCrossRef Schillinger D, Grumbach K, Piette J. Association of health literacy with diabetes outcomes. JAMA 2002; 288(4): 475–82PubMedCrossRef
64.
Zurück zum Zitat Cavanaugh K, Huizinga MM, Wallston KA. Association of numeracy and diabetes control. Ann Intern Med 2008; 148: 737–46PubMed Cavanaugh K, Huizinga MM, Wallston KA. Association of numeracy and diabetes control. Ann Intern Med 2008; 148: 737–46PubMed
65.
Zurück zum Zitat ADVANCE Collaborative Group. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet 2007; 370: 829–40CrossRef ADVANCE Collaborative Group. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet 2007; 370: 829–40CrossRef
66.
Zurück zum Zitat The Heart Outcomes Prevention Evaluation (HOPE) Study investigators. Effects of ramipril on cardiovascular and microvascular outcomes in MICROHOPE substudy. Lancet 2000; 355: 253–9CrossRef The Heart Outcomes Prevention Evaluation (HOPE) Study investigators. Effects of ramipril on cardiovascular and microvascular outcomes in MICROHOPE substudy. Lancet 2000; 355: 253–9CrossRef
67.
Zurück zum Zitat Zanchetti A, Grassi G, Mancia G. When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical reappraisal. J Hypertens 2009; 27: 923–34PubMedCrossRef Zanchetti A, Grassi G, Mancia G. When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical reappraisal. J Hypertens 2009; 27: 923–34PubMedCrossRef
68.
Zurück zum Zitat Zanchetti A, Mancia G, Black HR. Facts and fallacies of blood pressure control in recent trials: implications in the management of patients with hypertension. J Hypertens 2009, 27: 673–9PubMedCrossRef Zanchetti A, Mancia G, Black HR. Facts and fallacies of blood pressure control in recent trials: implications in the management of patients with hypertension. J Hypertens 2009, 27: 673–9PubMedCrossRef
69.
Zurück zum Zitat Wu JS, Yang YC, Lu FH. Population-based study on the prevalence and risk factors of orthostatic hypotension in subjects with pre-diabetes and diabetes. Diabetes Care 2009; 32: 69–74PubMedCrossRef Wu JS, Yang YC, Lu FH. Population-based study on the prevalence and risk factors of orthostatic hypotension in subjects with pre-diabetes and diabetes. Diabetes Care 2009; 32: 69–74PubMedCrossRef
70.
Zurück zum Zitat Luukinen H, Koski K, Laippala P, Kivelä SL. Prognosis of diastolic and systolic orthostatic hypotension in older persons. Arch Intern Med 1999; 159: 273–80PubMedCrossRef Luukinen H, Koski K, Laippala P, Kivelä SL. Prognosis of diastolic and systolic orthostatic hypotension in older persons. Arch Intern Med 1999; 159: 273–80PubMedCrossRef
71.
Zurück zum Zitat Hiitola P, Enlund H, Kettunen R, Postural changes in blood pressure and the prevalence of orthostatic hypotension among home-dwelling elderly aged 75 years or older. J Hum Hypertens 2009 Jan; 23: 33–9PubMedCrossRef Hiitola P, Enlund H, Kettunen R, Postural changes in blood pressure and the prevalence of orthostatic hypotension among home-dwelling elderly aged 75 years or older. J Hum Hypertens 2009 Jan; 23: 33–9PubMedCrossRef
72.
Zurück zum Zitat Mangoni AA, Jackson HD. The implications of a growing evidence base for drug use in elderly patients. Part 1. Statins for primary and secondary cardiovascular prevention. Br J Clin Pharmacol 2006; 61(5): 494–501PubMedCrossRef Mangoni AA, Jackson HD. The implications of a growing evidence base for drug use in elderly patients. Part 1. Statins for primary and secondary cardiovascular prevention. Br J Clin Pharmacol 2006; 61(5): 494–501PubMedCrossRef
73.
Zurück zum Zitat Brugts JJ, Yetgin T, Hoeks SE. The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials. BMJ 338: b2376. doi: 10.1136/bmj.b2376 Brugts JJ, Yetgin T, Hoeks SE. The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials. BMJ 338: b2376. doi: 10.1136/bmj.b2376
74.
Zurück zum Zitat Cholesterol Treatment Trialists’ (CTT) Collaborators Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet 2008; 371: 117–25CrossRef Cholesterol Treatment Trialists’ (CTT) Collaborators Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet 2008; 371: 117–25CrossRef
75.
Zurück zum Zitat Cholesterol Treatment Trialists’ (CTT) Collaborators Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90056 participants in 14 randomised trials of statins. Lancet 2005; 366: 1267–78CrossRef Cholesterol Treatment Trialists’ (CTT) Collaborators Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90056 participants in 14 randomised trials of statins. Lancet 2005; 366: 1267–78CrossRef
Metadaten
Titel
Development of CRIteria to Assess Appropriate Medication Use among Elderly Complex Patients (CRIME) Project
Rationale and Methodology
verfasst von
Domenico Fusco
Fabrizia Lattanzio
Matteo Tosato
Andrea Corsonello
Antonio Cherubini
Stefano Volpato
Cinzia Maraldi
Carmelinda Ruggiero
Dr Graziano Onder
Publikationsdatum
01.12.2009
Verlag
Springer International Publishing
Erschienen in
Drugs & Aging / Ausgabe Sonderheft 1/2009
Print ISSN: 1170-229X
Elektronische ISSN: 1179-1969
DOI
https://doi.org/10.2165/11534620-000000000-00000

Weitere Artikel der Sonderheft 1/2009

Drugs & Aging 1/2009 Zur Ausgabe

EditorialNotes

Foreword

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.